-$49,000
Est. value of DGX Stock Transactions by US Politicians Over the Past 2 Years.

Sign up to access historical data

Sign up

Trades by US Politicians

Politician Filing Date Type Size
Ro Khanna
Nov 15, 2024Buy$1K - $15K
Earl Blumenauer
Democrat
Apr 4, 2024Sell$1K - $15K
Rohit Khanna
Democrat
Feb 13, 2024Sell$1K - $15K
Rohit Khanna
Democrat
Feb 13, 2024Sell$1K - $15K
Thomas Tuberville
Republican
Jan 3, 2024Sell$15K - $50K
Thomas Carper
Democrat
Dec 11, 2023Sell$1K - $15K
Rohit Khanna
Democrat
Oct 31, 2023Buy$1K - $15K
Rohit Khanna
Democrat
Sep 6, 2023Sell$1K - $15K
Rohit Khanna
Democrat
Jun 29, 2023Buy$1K - $15K

Who is the latest politician to buy or sell Quest Diagnostics shares?

Ro Khanna purchased Quest Diagnostics shares most recently on November 15, 2024.

Which politician has bought the most DGX stock in the last two years?

Rohit Khanna has bought the most DGX stock in the last 2 years, with an estimated value of $16,000.

Which politician has sold the most DGX stock over the last two years?

Thomas Tuberville has sold the most DGX stock in the last 2 years, with an estimated value of $33,000.

What is the total value of politicians trading DGX stock in the last 2 years?

The net value of trades by US politicians for Quest Diagnostics in the last 2 years is negative, amounting to -$49,000. This suggests that US politicians do not believe in the success of the company for various reasons.

How do insider transactions over the last 2 years reflect on Quest Diagnostics' market confidence?

Over the last 2 years, insider transactions for Quest Diagnostics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.

Why should individual investors pay attention to the stock transactions of US politicians?

Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.